Spleen B cells from BALB/c are more prone to activation than spleen B cells from C57BL/6 mice during a secondary immune response to cruzipain.

There is an increasing interest in the study of roles that B cells may play in regulating immune responses both in protection and in pathogenesis. However, little is known about additional immune functions of B cells independently of antibody production. In this study, we have assessed how the immunization with T-dependent antigens in different host genetic backgrounds affects several parameters of B cells during secondary immune responses. We have previously reported that BALB/c immunized with cruzipain, induced heart autoimmunity, whereas C57BL/6 mice were resistant. In a comparative study employing the same experimental model, we demonstrated that BALB/c-enriched spleen B cells presented higher ability to proliferate releasing elevated levels of IL-4. Moreover, spleen of immune BALB/c mice presented an increased number of germinal center and plasma cells as well as higher expression of B-cell activation markers (MHC class II, CD40, CD86). These findings demonstrate the influence of genetic background on B-cell activation and emphasize the importance of examining B-cell behavior in the context of the specific immunogens.

[1]  M. Crow.  Modification of accessory molecule signaling , 2006, Springer Seminars in Immunopathology.

[2]  Chad W. Euler,et al.  B Cell Tolerance Checkpoints That Restrict Pathways of Antigen-Driven Differentiation1 , 2006, The Journal of Immunology.

[3]  F. Lund,et al.  Cutting Edge: The Development of IL-4-Producing B Cells (B Effector 2 Cells) Is Controlled by IL-4, IL-4 Receptor α, and Th2 Cells1 , 2005, The Journal of Immunology.

[4]  Y. Tomita,et al.  Prognostic significance of CD40 expression in malignant lymphoma developing in rheumatoid arthritis , 2005, Journal of Cancer Research and Clinical Oncology.

[5]  T. Delovitch,et al.  Dysregulated B7-1 and B7-2 Expression on Nonobese Diabetic Mouse B Cells Is Associated with Increased T Cell Costimulation and the Development of Insulitis1 , 2005, The Journal of Immunology.

[6]  R. Cano,et al.  Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice. , 2004, Microbes and infection.

[7]  T. Delovitch,et al.  Hyperresponsiveness, resistance to B-cell receptor-dependent activation-induced cell death, and accumulation of hyperactivated B-cells in islets is associated with the onset of insulitis but not type 1 diabetes. , 2004, Diabetes.

[8]  M. Clark,et al.  B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway. , 2004, Current opinion in immunology.

[9]  M. Duddy,et al.  Distinct Profiles of Human B Cell Effector Cytokines: A Role in Immune Regulation?1 , 2004, The Journal of Immunology.

[10]  R. Carsetti,et al.  Peripheral development of B cells in mouse and man , 2004, Immunological reviews.

[11]  S. Michalek,et al.  Role of B7 Costimulatory Molecules in Immune Responses and T-Helper Cell Differentiation in Response to Recombinant HagB from Porphyromonas gingivalis , 2004, Infection and Immunity.

[12]  P. Lipsky,et al.  Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. , 2003, The Journal of clinical investigation.

[13]  Jessie-F. Fecteau,et al.  CD40 Stimulation of Human Peripheral B Lymphocytes: Distinct Response from Naive and Memory Cells1 , 2003, The Journal of Immunology.

[14]  F. Kierszenbaum.  Views on the autoimmunity hypothesis for Chagas disease pathogenesis. , 2003, FEMS immunology and medical microbiology.

[15]  R. Parkhouse,et al.  A differential requirement for phosphoinositide 3‐kinase reveals two pathways for inducible upregulation of major histocompatibility complex class II molecules and CD86 expression by murine B lymphocytes , 2003, Immunology.

[16]  D. Engman,et al.  The significance of autoimmunity in the pathogenesis of Chagas heart disease. , 2003, Frontiers in bioscience : a journal and virtual library.

[17]  A. Rópolo,et al.  CpG‐DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice , 2002, Journal of leukocyte biology.

[18]  J. Kearney,et al.  CD9 Is a Unique Marker for Marginal Zone B Cells, B1 Cells, and Plasma Cells in Mice1 , 2002, The Journal of Immunology.

[19]  S. Gea,et al.  Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite , 2002, European journal of immunology.

[20]  C. Borrebaeck,et al.  Germinal Center B Cells Constitute a Predominant Physiological Source of IL-4: Implication for Th2 Development In Vivo1 , 2002, The Journal of Immunology.

[21]  K. Calame,et al.  Plasma cells: finding new light at the end of B cell development , 2001, Nature Immunology.

[22]  S. Swain,et al.  Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.

[23]  M. Fresno,et al.  Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain‐immunized mice and their offspring , 2000, European journal of immunology.

[24]  N. Baumgarth,et al.  A two‐phase model of B‐cell activation , 2000, Immunological reviews.

[25]  R. Noelle,et al.  Identification of Murine Germinal Center B Cell Subsets Defined by the Expression of Surface Isotypes and Differentiation Antigens1 , 2000, The Journal of Immunology.

[26]  P. Lehmann,et al.  Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. , 1999, Journal of immunology.

[27]  D. Tarlinton,et al.  Kinetics of establishing the memory B cell population as revealed by CD38 expression. , 1998, Journal of immunology.

[28]  Chand,et al.  Differential regulation of expression of the MHC class II molecules RT1.B and RT1.D on rat B lymphocytes: effects of interleukin‐4, interleukin‐13 and interferon‐γ , 1998, Immunology.

[29]  K. Okumura,et al.  Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. , 1997, International immunology.

[30]  S. Gea,et al.  Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII). , 1996, International journal for parasitology.

[31]  J. Gribben,et al.  B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. , 1995, Immunity.

[32]  M. Miles.  Control of Chagas disease. Report of a WHO Expert Committee. , 1993, World Health Organization technical report series.

[33]  S. Reed,et al.  Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase. , 1993, Journal of immunology.

[34]  Hwei-Ling Cheng,et al.  Distinct IL-4 response mechanisms of the MHC gene Aα in different mouse B cell lines , 1993 .

[35]  R. Zinkernagel,et al.  Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.

[36]  Martin Bachmann,et al.  Disruption of the murine IL-4 gene blocks Th2 cytokine responses , 1993, Nature.

[37]  A. Coutinho,et al.  Differential expression of VH gene families in peripheral B cell repertoires of newborn or adult immunoglobulin H chain congenic mice , 1992, The Journal of experimental medicine.

[38]  W. de Souza,et al.  Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction. , 1990, Journal of cell science.

[39]  J. Cazzulo,et al.  Some kinetic properties of a cysteine proteinase (cruzipain) from Trypanosoma cruzi. , 1990, Biochimica et biophysica acta.

[40]  J. Banchereau,et al.  Activation of human B lymphocytes through CD40 and interleukin 4 , 1989, European journal of immunology.

[41]  R. Noelle,et al.  A cell surface ELISA to detect interleukin-4-induced class II MHC expression on murine B cells. , 1987, Journal of immunological methods.

[42]  Y. Yamagata,et al.  Control of Chagas disease. , 2006, Advances in parasitology.

[43]  L. Erickson,et al.  Determinations of B cell fate in immunity and autoimmunity. , 2005, Current directions in autoimmunity.

[44]  T. Randall,et al.  Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. , 2005, Current directions in autoimmunity.

[45]  A. Bhan,et al.  A Case for Regulatory B Cells , 2005 .

[46]  T. Waldschmidt,et al.  The germinal center response. , 2004, Critical reviews in immunology.

[47]  M. Fresno,et al.  Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? , 2003, Trends in parasitology.

[48]  R. Ceredig,et al.  Both IFN-γ and IL-4 Induce MHC Class II Expression at the Surface of Mouse Pro-B Cells , 1997, Developmental Immunology.

[49]  M. Boothby,et al.  Distinct IL-4 response mechanisms of the MHC gene A alpha in different mouse B cell lines. , 1993, Molecular immunology.